Early pre-order discount for consumers who reserve a SmartCemic device before the official product launch.
Example promotion
This is an example of a promotion that could suit this business. It is not a guaranteed active offer or a working discount code. Check the website for current deals.
To the shop
NorCemic is an American health technology company developing the SmartCemic QESA Pro, a non-invasive device that claims to monitor over 114 biomarkers, including glucose and hormones, using quantum-enhanced spectral analysis rather than blood draws. The company is currently in the pre-order phase while the device undergoes FDA review.
Your review = Donation to charity + chance on €250
Two minutes of your time. One donation to a good cause, plus a monthly cash raffle.
Photo reviews
No glossy product shots, but what customers actually receive at home.
Impact via Norcemic
You write a review, we donate to a good cause on your behalf.
No donations have been made for Norcemic yet, but every review sets one in motion right away.
Is Norcemic your business? Claim this page for free →
About Norcemic
Founded
2023
Headquarters
Phoenix, Arizona, United States
Product status
Pre-order only, final prototype stage
Regulatory status
FDA Breakthrough Device Designation submitted April 2026
Biomarkers tracked
114+
Target accuracy
±5% (ISO 15197 standard)
Manufacturing partner
Voltas Medical LLC (ISO 13485 certified)
Crowdfunding platforms
StartEngine and Indiegogo
NorCemic positions itself in the emerging segment of non-invasive personal health monitoring, targeting consumers who want continuous biomarker tracking without needles or laboratory visits. The company operates from Phoenix, Arizona, and was founded in 2023 by a team of engineers, data scientists, and medical professionals. Its stated philosophy centers on accessibility, specifically designing for all skin tones across the Monk scale and ensuring HIPAA-compliant data handling. The product is not yet commercially available. Pre-orders are open while the SmartCemic QESA Pro advances through FDA regulatory review and final prototype manufacturing with partner Voltas Medical LLC.
Active promotions
Ready to use with your order at Norcemic.
Free companion app subscription for a set period included with a pre-order of the SmartCemic QESA Pro.
Example promotion
This is an example of a promotion that could suit this business. It is not a guaranteed active offer or a working discount code. Check the website for current deals.
To the shop
Norcemic in the news
Recent updates and background about Norcemic, summarised in our own words.
NorCemic named Most Innovative Non-Invasive Blood Monitoring Technology Company 2026
NorCemic received the Global Health and Pharma award for Most Innovative Non-Invasive Blood Monitoring Technology Company in 2026. The recognition highlights the company's development of quantum-enhanced spectral analysis for biomarker monitoring.
SmartCemic QESA Pro feasibility test achieves 7.61% MARD for glucose monitoring
NorCemic published results from an early prototype feasibility demonstration comparing the SmartCemic QESA Pro against an FDA-cleared Contour glucometer. The test recorded a Mean Absolute Relative Difference of 7.61%, which falls within the ISO 15197:2013 clinical accuracy threshold.
NorCemic submits FDA Breakthrough Device Designation in April 2026
NorCemic announced the submission of a Breakthrough Device Designation to the FDA in April 2026 for the SmartCemic QESA Pro. The device is currently in final prototype manufacturing with ISO 13485 certified partner Voltas Medical LLC.
Summaries by Image Review based on publicly available sources and our own editing. External links may contain affiliate links.
What others ask about Norcemic
Answers to the most common questions, based on search behaviour and our own research.
Is NorCemic a reliable company to buy from?
NorCemic is a startup founded in 2023 that is currently in the pre-order phase. The SmartCemic device has not yet received FDA clearance, and the company itself notes that clinical validation studies are still underway. Consumers should be aware that pre-ordering involves uncertainty about delivery timelines and final product performance.
When will the SmartCemic QESA Pro actually ship?
According to NorCemic, pre-orders will ship upon completion of the final prototype stage with manufacturing partner Voltas Medical LLC. No specific shipping date is publicly confirmed, as delivery depends on the outcome of ongoing FDA review and manufacturing completion.
Has the SmartCemic device been approved by the FDA?
As of April 2026, NorCemic has submitted a Breakthrough Device Designation to the FDA, but the device has not yet received FDA clearance or approval. The company states that a feasibility test achieved a MARD of 7.61% for glucose, though full clinical validation studies are still in progress.
Can I get a refund if I pre-order and the product is delayed or not delivered?
NorCemic does not publicly detail its refund or cancellation policy on the pages reviewed. Consumers considering a pre-order are advised to contact NorCemic directly and review the terms and conditions before committing funds, given the early-stage nature of the product.
Your turn
Do you have experience with Norcemic?
Help other consumers by sharing your experience, with a photo of what you actually received. It takes two minutes and you automatically join the monthly draw.
€250
cash per month
One winner from all review submitters, drawn on the 1st of the month.
Your review = real impact + chance to win €250
Guarantee: every review triggers one of these 5 real donations:
- 1 Upload a photo Of your order or the product
- 2 Give stars 1 to 5 per aspect
- 3 Trigger a donation Plus a chance at € 250 cash per month
Write a review
Share your photo review about Norcemic
A photo says more than a thousand words. Help other consumers with an honest experience and join the monthly draw for € 250 cash.
- Reviewing anonymously is fine, we only need your email
- No mandatory account, no registration
- Reviews appear after a check within 24 hours
- Monthly chance to win € 250 cash
